One of the most frightening things about Alzheimer's disease is how difficult it is to diagnose early. Now, University of Connecticut researchers report two fast tests for early markers of the disease ...

(CNN) — The U.S. Food and Drug Administration has given clearance to another blood test to help assess Alzheimer’s disease and other causes of cognitive decline, providing a broader understanding of ...

FDA cleared the Elecsys pTau181 test as the first blood-based biomarker to aid in the initial assessment of Alzheimer's disease and other causes of cognitive decline that can be used in the primary ...

The US Food and Drug Administration has given clearance to another blood test to help assess Alzheimer's disease and other causes of cognitive decline, providing a broader understanding of when the ...

An expert panel convened by the nation’s top post-acute care medical organization has recommended against the routine use of urine PCR tests to diagnose urinary tract infections. Such tests have ...

The U.S. FDA recently approved a new blood test to diagnose Alzheimer’s disease. The test, called Lumipulse, measures two proteins in plasma: pTau217 and ß-Amyloid 1-42. These proteins clump together ...

Researchers in Sweden and Finland have created the CORE model, a simple blood test that predicts liver disease risk with striking accuracy. Unlike current methods, it works for the general population ...

KANSAS CITY, Mo. — Children’s Mercy announced Monday that it has developed a “breakthrough” test to help diagnose genetic diseases in children. In a study published in the Journal of the American ...

In 2021, 57 million people across the planet were living with dementia. This class of memory-related diseases is the world’s seventh greatest killer, and Alzheimer’s disease is its most common form.